Human Pluripotent Stem Cell-derived Cardiomyocytes/Neurons on 3D Micro-Tissue Devices for Matured and Functional Cell Products in Drug Discovery and Screening
Norio Nakatsuji, Chief Advisor, Stem Cell & Device Laboratory, Inc. (SCAD); Professor Emeritus, Kyoto University
Human pluripotent stem (PS) cells, including ES and iPS cells, are
promising sources of various model cells for drug discovery and
toxicology screening. However, there are important (but still
unsatisfactory) needs of more matured and functional cells with reliable
and low-cost production from human iPS or ES cells. We developed a
method of robust and low-cost cytokine-free differentiation of
cardiomyocytes from human ES/iPS cells by combination of small chemical
compounds. We also developed low-cost and labor-saving methods for
construction of 3D multi-cellular devices with aligned nanofibers for
more matured and functional cell device products. Our human iPSC-derived
cardiomyocytes or neurons seeded on nanofiber scaffolds form 3D
multi-layered structures (Micro-Tissues), which show matured and stable
cell/tissue functions. Our Micro-Tissue devices are easy to handle and
useful for drug screening and toxicology assays.
|
|